10.05.2018 22:01:00
|
Alkermes' Corporate Presentation to be Webcast at the Bank of America Merrill Lynch Health Care Conference
DUBLIN, May 10, 2018 /PRNewswire/ -- Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 16, 2018 at 11:20 a.m. PT (2:20 p.m. ET/7:20 p.m. BST) from Las Vegas. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Contact:
Jennifer Zibuda
Corporate Communications
+1 781 609 6129
View original content with multimedia:http://www.prnewswire.com/news-releases/alkermes-corporate-presentation-to-be-webcast-at-the-bank-of-america-merrill-lynch-health-care-conference-300646304.html
SOURCE Alkermes plc
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Alkermes PLCmehr Nachrichten
23.10.24 |
Ausblick: Alkermes stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
23.07.24 |
Ausblick: Alkermes präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |